. Coyne and J. M. Bergelson, CAR: a virus receptor within the tight junction, Adv Drug Deliv Rev, vol.57, pp.869-882, 2005.

. Meier, . Greber, and . Uf, Adenovirus endocytosis, J Gene Med, vol.6, pp.152-163, 2004.

Y. Zhang and J. M. Bergelson, Adenovirus receptors, J Virol, vol.79, pp.12125-12131, 2005.

,. Einfeld, . Da, and P. W. Roelvink, Advances towards targetable adenovirus vectors for gene therapy, Curr Opin Mol Ther, vol.4, pp.444-451, 2002.

S. A. Nicklin, E. Wu, . Nemerow, and A. H. Baker, The influence of adenovirus fiber structure and function on vector development for gene therapy, Mol Ther, vol.12, pp.384-393, 2005.

T. Smith, N. Idamakanti, H. Kylefjord, M. Rollence, L. King et al., In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor, Mol Ther, vol.5, pp.770-779, 2002.

Y. Wang, J. K. Hu, A. Krol, Y. P. Li, . Li et al., Systemic dissemination of viral vectors during intratumoral injection, Mol Cancer Ther, vol.2, pp.1233-1242, 2003.

. Krasnykh, . Vn, . Douglas, and . Van-beusechem, Genetic targeting of adenoviral vectors, Mol Ther, vol.1, pp.391-405, 2000.

T. J. Wickham, . Carrion, and I. Kovesdi, Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs, Gene Ther, vol.2, pp.750-756, 1995.

E. Vigne, I. Mahfouz, . Dedieu, . Jf, A. Brie et al., RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection, J Virol, vol.73, pp.5156-5161, 1999.

E. Vigne, . Dedieu, . Jf, A. Brie, A. Gillardeaux et al., Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation, Gene Ther, vol.10, pp.153-162, 2003.

T. Nakamura, . Sato, and H. Hamada, Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber, J Virol, vol.77, pp.2512-2521, 2003.

M. A. Stoff-khalili, A. A. Rivera, . Glasgow, . Jn, . Le et al., A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy, Gene Ther, vol.12, pp.1696-1706, 2005.

A. Gaggar, . Shayakhmetov, and A. Lieber, CD46 is a cellular receptor for group B adenoviruses, Nat Med, vol.9, pp.1408-1412, 2003.

V. Seggern, . Dj, S. Huang, . Fleck, . Sk et al., , 2000.

, Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells, J Virol, vol.74, pp.354-362

K. Martin, A. Brie, P. Saulnier, M. Perricaudet, . Yeh et al., Simultaneous CAR-and ?V integrin-binding ablation fails to reduce Ad5 liver tropism, Mol Ther, vol.8, pp.485-494, 2003.

T. A. Smith, N. Idamakanti, . Rollence, . Ml, J. Marshall-neff et al., Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice, Hum Gene Ther, vol.14, pp.777-787, 2003.

A. B. Kritz, . Nicol, . Cg, . Dishart, . Kl et al., , 2007.

, Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop, Mol Ther, vol.15, pp.741-749

N. Bayo-puxan, M. Cascallo, A. Gros, M. Huch, A. Fillat et al., Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting, J Gen Virol, vol.87, pp.2487-2495, 2006.

K. R. Zinn, A. J. Szalai, A. Stargel, . Krasnykh, . Chaudhuri et al., Bioluminescence imaging reveals a significant role for complement in liver transduction following intravenous delivery of adenovirus, Gene Ther, vol.11, pp.1482-1486, 2004.

D. M. Shayakhmetov, A. Gaggar, S. Ni, . Li, and A. Lieber, Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity, J Virol, vol.79, pp.7478-7491, 2005.

A. L. Parker, . Waddington, . Sn, . Nicol, . Cg et al., Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes, Blood, vol.108, pp.2554-2561, 2006.

A. H. Baker, J. H. Mcvey, . Waddington, D. Sn, . Paolo et al., The influence of blood on in vivo adenovirus bio-distribution and transduction, Mol Ther, vol.15, pp.1410-1416, 2007.

A. L. Parker, J. H. Mcvey, J. H. Doctor, O. Lopez-franco, . Waddington et al., Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D, J Virol, vol.81, pp.3627-3631, 2007.

S. N. Waddington, A. L. Parker, M. Havenga, . Nicklin, . Sa et al., Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5, J Virol, vol.81, pp.9568-9571, 2007.

. Mane, . Vp, G. Toietta, W. M. Mccormack, I. Conde et al., Modulation of TNF-?, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors, Gene Ther, vol.13, pp.1272-1280, 2006.

R. Alemany, . Suzuki, . Curiel, and . Dt, Blood clearance rates of adenovirus type 5 in mice, J Gen Virol, vol.81, pp.2605-2609, 2000.

G. Schiedner, S. Hertel, M. Johnston, V. Dries, . Van-rooijen et al., Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors, Mol Ther, vol.7, pp.35-43, 2003.

S. N. Waddington, J. H. Mcvey, D. Bhella, A. L. Parker, K. Barker et al., Adenovirus serotype 5 hexon mediates liver gene transfer, Cell, vol.132, pp.397-409, 2008.

L. Denby, . Work, . Lm, . Seggern, . Dj et al., Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p, Mol Ther, vol.15, pp.1647-1654, 2007.

O. Kalyuzhniy, D. Paolo, . Nc, M. Silvestry, . Hofherr et al., Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo, Proc Natl Acad Sci, vol.105, pp.5483-5488, 2008.

D. Geest, B. Snoeys, J. , V. Linthout, S. Lievens et al., Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone, Hum Gene Ther, vol.16, pp.1439-1451, 2005.

N. Koizumi, T. Yamaguchi, K. Kawabata, F. Sakurai, T. Sasaki et al., Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production, J Immunol, vol.178, pp.1767-1773, 2007.

L. C. Trotman, N. Mosberger, M. Fornerod, . Stidwill, . Greber et al., Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1, Nat Cell Biol, vol.3, pp.1092-1100, 2001.

F. Sakurai, H. Mizuguchi, . Yamaguchi, and T. Hayakawa, Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector, Mol Ther, vol.8, pp.813-821, 2003.

D. M. Roberts, A. Nanda, . Havenga, . Mj, P. Abbink et al., , 2006.

, Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity, Nature, vol.441, pp.239-243

H. Wu, T. Han, N. Belousova, V. Krasnykh, E. Kashentseva et al., Identification of sites in adenovirus hexon for foreign peptide incorporation, J Virol, vol.79, pp.3382-3390, 2005.

F. Blanche, B. Cameron, A. Barbot, L. Ferrero, T. Guillemin et al., An improved anion-exchange HPLC method for the detection and purification of adenoviral particles, Gene Ther, vol.7, pp.1055-1062, 2000.

A. Nicou, V. Serriere, M. Hilly, S. Prigent, L. Combettes et al., Remodelling of calcium signalling during liver regeneration in the rat, J Hepatol, vol.46, pp.247-256, 2007.